General Information of Drug Off-Target (DOT) (ID: OTL4Z99V)

DOT Name A-kinase anchor protein 4 (AKAP4)
Synonyms AKAP-4; A-kinase anchor protein 82 kDa; AKAP 82; hAKAP82; Major sperm fibrous sheath protein; HI; Protein kinase A-anchoring protein 4; PRKA4
Gene Name AKAP4
Related Disease
Cervical cancer ( )
Cervical carcinoma ( )
Squamous cell carcinoma ( )
Advanced cancer ( )
Colon cancer ( )
Colon carcinoma ( )
Colorectal carcinoma ( )
Male infertility ( )
Non-small-cell lung cancer ( )
Pituitary tumor ( )
Testicular cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Breast lobular carcinoma ( )
Gastric cancer ( )
Neoplasm ( )
Stomach cancer ( )
Thyroid cancer ( )
Thyroid gland carcinoma ( )
Thyroid tumor ( )
UniProt ID
AKAP4_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF05716 ; PF10522
Sequence
MMAYSDTTMMSDDIDWLRSHRGVCKVDLYNPEGQQDQDRKVICFVDVSTLNVEDKDYKDA
ASSSSEGNLNLGSLEEKEIIVIKDTEKKDQSKTEGSVCLFKQAPSDPVSVLNWLLSDLQK
YALGFQHALSPSTSTCKHKVGDTEGEYHRASSENCYSVYADQVNIDYLMNRPQNLRLEMT
AAKNTNNNQSPSAPPAKPPSTQRAVISPDGECSIDDLSFYVNRLSSLVIQMAHKEIKEKL
EGKSKCLHHSICPSPGNKERISPRTPASKIASEMAYEAVELTAAEMRGTGEESREGGQKS
FLYSELSNKSKSGDKQMSQRESKEFADSISKGLMVYANQVASDMMVSLMKTLKVHSSGKP
IPASVVLKRVLLRHTKEIVSDLIDSCMKNLHNITGVLMTDSDFVSAVKRNLFNQWKQNAT
DIMEAMLKRLVSALIGEEKETKSQSLSYASLKAGSHDPKCRNQSLEFSTMKAEMKERDKG
KMKSDPCKSLTSAEKVGEHILKEGLTIWNQKQGNSCKVATKACSNKDEKGEKINASTDSL
AKDLIVSALKLIQYHLTQQTKGKDTCEEDCPGSTMGYMAQSTQYEKCGGGQSAKALSVKQ
LESHRAPGPSTCQKENQHLDSQKMDMSNIVLMLIQKLLNENPFKCEDPCEGENKCSEPRA
SKAASMSNRSDKAEEQCQEHQELDCTSGMKQANGQFIDKLVESVMKLCLIMAKYSNDGAA
LAELEEQAASANKPNFRGTRCIHSGAMPQNYQDSLGHEVIVNNQCSTNSLQKQLQAVLQW
IAASQFNVPMLYFMGDKDGQLEKLPQVSAKAAEKGYSVGGLLQEVMKFAKERQPDEAVGK
VARKQLLDWLLANL
Function Major structural component of sperm fibrous sheath. Plays a role in sperm motility.
Tissue Specificity Testis specific; only expressed in round spermatids.

Molecular Interaction Atlas (MIA) of This DOT

20 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cervical cancer DISFSHPF Definitive Altered Expression [1]
Cervical carcinoma DIST4S00 Definitive Altered Expression [1]
Squamous cell carcinoma DISQVIFL Definitive Biomarker [1]
Advanced cancer DISAT1Z9 Strong Biomarker [2]
Colon cancer DISVC52G Strong Altered Expression [3]
Colon carcinoma DISJYKUO Strong Altered Expression [3]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [3]
Male infertility DISY3YZZ Strong Biomarker [4]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [5]
Pituitary tumor DISN67JD Strong Biomarker [5]
Testicular cancer DIS6HNYO Strong Biomarker [6]
Breast cancer DIS7DPX1 Limited Altered Expression [7]
Breast carcinoma DIS2UE88 Limited Altered Expression [7]
Breast lobular carcinoma DISBY98Q Limited Genetic Variation [7]
Gastric cancer DISXGOUK Limited Biomarker [8]
Neoplasm DISZKGEW Limited Biomarker [9]
Stomach cancer DISKIJSX Limited Biomarker [8]
Thyroid cancer DIS3VLDH Limited Biomarker [9]
Thyroid gland carcinoma DISMNGZ0 Limited Biomarker [9]
Thyroid tumor DISLVKMD Limited Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 20 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of A-kinase anchor protein 4 (AKAP4). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of A-kinase anchor protein 4 (AKAP4). [11]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of A-kinase anchor protein 4 (AKAP4). [12]
------------------------------------------------------------------------------------

References

1 Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo.Cancer Gene Ther. 2013 Jul;20(7):413-20. doi: 10.1038/cgt.2013.32. Epub 2013 Jun 14.
2 Genome-wide analysis of cancer/testis gene expression.Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20422-7. doi: 10.1073/pnas.0810777105. Epub 2008 Dec 16.
3 A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.J Exp Clin Cancer Res. 2015 Nov 21;34:142. doi: 10.1186/s13046-015-0258-y.
4 A-kinase anchor protein 4 precursor (pro-AKAP4) in human spermatozoa.Andrology. 2018 Nov;6(6):854-859. doi: 10.1111/andr.12524. Epub 2018 Jul 8.
5 Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.Oncotarget. 2015 Feb 20;6(5):2812-26. doi: 10.18632/oncotarget.2802.
6 Role of A-Kinase anchor protein (AKAP4) in growth and survival of ovarian cancer cells.Oncotarget. 2017 May 24;8(32):53124-53136. doi: 10.18632/oncotarget.18163. eCollection 2017 Aug 8.
7 A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer.PLoS One. 2013;8(2):e57095. doi: 10.1371/journal.pone.0057095. Epub 2013 Feb 22.
8 Knockdown of A-kinase anchor protein 4 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/-catenin pathway in human gastric cancer cells.J Cell Biochem. 2018 Dec;119(12):10013-10020. doi: 10.1002/jcb.27331. Epub 2018 Aug 26.
9 Silencing of A-Kinase Anchor Protein 4 (AKAP4) Inhibits Proliferation and Progression of Thyroid Cancer.Oncol Res. 2017 Jul 5;25(6):873-878. doi: 10.3727/096504016X14783701102564. Epub 2016 Nov 8.
10 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
11 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
12 Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep. 2016 Dec 1;6:37842. doi: 10.1038/srep37842.